Capital International Inc. CA acquired a new stake in Cardinal Health, Inc. (NYSE:CAH – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor acquired 9,902 shares of the company’s stock, valued at approximately $2,035,000.
Other hedge funds also recently made changes to their positions in the company. Aventura Private Wealth LLC acquired a new position in shares of Cardinal Health in the 4th quarter valued at $25,000. Elyxium Wealth LLC acquired a new position in shares of Cardinal Health in the 4th quarter valued at $34,000. Barnes Dennig Private Wealth Management LLC raised its stake in shares of Cardinal Health by 38.7% in the 4th quarter. Barnes Dennig Private Wealth Management LLC now owns 190 shares of the company’s stock valued at $39,000 after buying an additional 53 shares in the last quarter. JPL Wealth Management LLC acquired a new position in shares of Cardinal Health in the 3rd quarter valued at $31,000. Finally, Turning Point Benefit Group Inc. acquired a new position in shares of Cardinal Health in the 3rd quarter valued at $31,000. Institutional investors and hedge funds own 87.17% of the company’s stock.
Cardinal Health Stock Down 0.6%
Shares of Cardinal Health stock opened at $204.56 on Tuesday. The stock has a market capitalization of $47.91 billion, a P/E ratio of 31.28, a price-to-earnings-growth ratio of 1.12 and a beta of 0.52. The company has a 50-day simple moving average of $202.47 and a 200 day simple moving average of $208.57. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $233.60.
Cardinal Health Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a yield of 1.0%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is currently 31.19%.
Wall Street Analyst Weigh In
CAH has been the subject of a number of recent research reports. Wells Fargo & Company dropped their price objective on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Morgan Stanley increased their price objective on shares of Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a research note on Tuesday, April 28th. Citigroup dropped their target price on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a research report on Friday, May 1st. Robert W. Baird set a $248.00 target price on shares of Cardinal Health in a research report on Friday, May 1st. Finally, Leerink Partners reiterated an “outperform” rating and set a $275.00 target price on shares of Cardinal Health in a research report on Monday, March 9th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $241.80.
View Our Latest Stock Analysis on CAH
Cardinal Health Profile
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Read More
- Five stocks we like better than Cardinal Health
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
